Medical Properties Trust (NYSE:MPT – Get Free Report) is one of 90 public companies in the “Real Estate Investment Trusts” industry, but how does it compare to its peers? We will compare Medical Properties Trust to similar companies based on the strength of its risk, profitability, valuation, earnings, analyst recommendations, dividends and institutional ownership.
Earnings and Valuation
This table compares Medical Properties Trust and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Medical Properties Trust | $933.52 million | -$277.05 million | -12.59 |
| Medical Properties Trust Competitors | $463.09 million | $16.35 million | 26.60 |
Medical Properties Trust has higher revenue, but lower earnings than its peers. Medical Properties Trust is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Medical Properties Trust | -28.50% | -5.83% | -1.85% |
| Medical Properties Trust Competitors | -34.14% | -18.20% | -0.23% |
Institutional & Insider Ownership
71.8% of Medical Properties Trust shares are held by institutional investors. Comparatively, 63.7% of shares of all “Real Estate Investment Trusts” companies are held by institutional investors. 1.3% of Medical Properties Trust shares are held by insiders. Comparatively, 7.9% of shares of all “Real Estate Investment Trusts” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Dividends
Medical Properties Trust pays an annual dividend of $0.36 per share and has a dividend yield of 6.2%. Medical Properties Trust pays out -78.3% of its earnings in the form of a dividend. As a group, “Real Estate Investment Trusts” companies pay a dividend yield of 4.0% and pay out 102.7% of their earnings in the form of a dividend. Medical Properties Trust is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Medical Properties Trust and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Medical Properties Trust | 1 | 0 | 1 | 0 | 2.00 |
| Medical Properties Trust Competitors | 2346 | 4059 | 2396 | 22 | 2.01 |
Medical Properties Trust currently has a consensus target price of $8.00, indicating a potential upside of 38.17%. As a group, “Real Estate Investment Trusts” companies have a potential upside of 15.39%. Given Medical Properties Trust’s higher probable upside, research analysts plainly believe Medical Properties Trust is more favorable than its peers.
Risk & Volatility
Medical Properties Trust has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Medical Properties Trust’s peers have a beta of 1.15, suggesting that their average share price is 15% more volatile than the S&P 500.
Summary
Medical Properties Trust beats its peers on 9 of the 15 factors compared.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.
